Human Immunodeficiency Virus Infection and Acquired Immune Deficiency Syndrome in Uganda: A Mini Situational Review
DOI:
https://doi.org/10.17140/HARTOJ-9-138Keywords:
HIV/AIDS, Uganda, Strategies, Situational analysisAbstract
Globally, human immunodeficiency virus (HIV) infection is a major public health concern and several countries continuously lay down strategies to contain this pandemic. In Uganda, the government is committed to putting an end to new cases of HIV transmission. According to the latest Joint United Nations Programme on HIV/AIDS (UNAIDS) estimates, since the start of the global HIV/AIDS pandemic, over 75 million people have been infected with HIV and over 32 million people have died from acquired immune deficiency syndrome (AIDS) related illnesses. As of June 2021, UNAIDS estimated that globally, there were about 38 million people living with HIV (PLHIV) with the East and Southern African countries, home to 700 million people, contributing 45%. Uganda has an estimated 1.4 million people living with HIV of which 1.3 million are currently on treatment (Ministry of Health (MoH) Annual Estimates 2021). The country has registered a 37% decline in AIDS annual related deaths, from 27,000 in 2016 to 17,000 in 2021. New HIV infections in 2021 stood at 54,000. This review will highlight some of the efforts put in place to ensure that by 2030 AIDS will not be a public health threat to Ugandans.
References
Uganda AIDS Commission. Office of the President. Presidential Fast-track Initiative on Ending HIV&AIDS in Uganda: A Presidential Handbook. Kampala, Uganda: Republic of Uganda; 2017.
Uganda Population-Based HIV Impact Assessment (UP-HIA). Uganda population-based HIV impact assessment (UP-HIA) 2016-2017. Website. https://phia.icap.columbia.edu/ wp-content/uploads/2019/07/UPHIA_Final_Report_Re-vise_07.11.2019_Final_for-web.pdf. Accessed March 29, 2023.
National Research Council. Preventing and Mitigating AIDS in Sub-Saharan Africa: Research and Data Priorities for the Social and Behavioral Sciences. Washington (DC): National Academies Press (US); 1996: 155-203. doi: 10.17226/5177
Joint United Nations Programme on HIV/AIDS (UNAIDS). UNAIDS data 2021. Website. https://www.unaids.org/sites/ default/files/media_asset/JC3032_AIDS_Data_book_2021_ En.pdf. Accessed March 29, 2023.
Okware S, Kinsman J, Onyango S, Opio A, Kaggwa P. Revisit-ing the ABC strategy: HIV prevention in Uganda in the era of antiretroviral therapy. Postgrad Med J. 2005; 81(960): 625-628. doi: 10.1136/pgmj.2005.032425
Ssenyonga J, Potts L. Bridging the gap from data to evidence-based HIV prevention in Uganda. Procedia -Social and Behavioral Sci-ences. 2014; 140: 343-347. doi: 10.1016/j.sbspro.2014.04.432
Türmen T. Gender and HIV/AIDS. Int J Gynaecol Obstet. 2003; 82(3): 411-418. doi: 10.1016/s0020-7292(03)00202-9
World Health Organization (WHO), Joint United Nations Programme on HIV/AIDS (UNAIDS). Global AIDS responce progress reporting 2015. 2015. Website. https://www.unaids.org/ sites/default/files/media_asset/JC2702_GARPR2015guidelines_ en.pdf. Accessed March 29, 2023. Mini Review | Volume 9 | Number 1 |
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in HIV/AIDS Research and Treatment (HRT) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.
